Julien Favresse

InstitutionDepartment of Laboratory Medicine
AddressNamur
Belgium
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 24 Covid-19 publications, with a maximum of 4 publications in August 2021
    All Publications
    Bar chart showing 35 publications over 5 distinct years, with a maximum of 15 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Favresse J, Bayart JL, Mullier F, Elsen M, Eucher C, Van Eeckhoudt S, Roy T, Wieers G, Laurent C, Dogné JM, Closset M, Douxfils J. Antibody titres decline 3-month post-vaccination with BNT162b2. Emerg Microbes Infect. 2021 Dec; 10(1):1495-1498. PMID: 34232116.
      Citations: 25     Fields:    Translation:HumansPHPublic Health
    2. Douxfils J, Gillot C, Mullier F, Favresse J. Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ. J Infect. 2021 10; 83(4):e4-e5. PMID: 34407421.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    3. Douxfils J, Gillot C, De Gottal É, Vandervinne S, Bayart JL, Dogné JM, Favresse J. Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature. Vaccines (Basel). 2021 Aug 15; 9(8). PMID: 34452032.
      Citations: 3     
    4. Douxfils J, Vayne C, Pouplard C, Lecompte T, Favresse J, Potier F, Gasser E, Mathieux V, Dogné JM, Gruel Y, Rollin J, Mullier F. Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels. Haematologica. 2021 08 12. PMID: 34382387.
      Citations:    Fields:    
    5. Gillot C, Favresse J, Mullier F, Lecompte T, Dogné JM, Douxfils J. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments. Front Pharmacol. 2021; 12:708302. PMID: 34421600.
      Citations: 1     
    6. Favresse J, Gillot C, Di Chiaro L, Eucher C, Elsen M, Van Eeckhoudt S, David C, Morimont L, Dogné JM, Douxfils J. Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2. Viruses. 2021 07 14; 13(7). PMID: 34372570.
      Citations: 11     Fields:    Translation:Humans
    7. Favresse J, Douxfils J. Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination. J Infect. 2022 01; 84(1):94-118. PMID: 34233149.
      Citations:    Fields:    Translation:HumansPHPublic Health
    8. Bayart JL, Morimont L, Closset M, Wieërs G, Roy T, Gerin V, Elsen M, Eucher C, Van Eeckhoudt S, Ausselet N, David C, Mullier F, Dogné JM, Favresse J, Douxfils J. Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2. Microorganisms. 2021 Jun 21; 9(6). PMID: 34205564.
      Citations: 7     
    9. Favresse J, Douxfils J. Evaluations of SARS-CoV-2 Serological Assay Performance Need Inclusion of Long-Term Samples. J Clin Microbiol. 2021 05 19; 59(6). PMID: 33758035.
      Citations: 1     Fields:    Translation:Humans
    10. Douxfils J, Favresse J, Dogné JM, Lecompte T, Susen S, Cordonnier C, Lebreton A, Gosselin R, Sié P, Pernod G, Gruel Y, Nguyen P, Vayne C, Mullier F. Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res. 2021 07; 203:163-171. PMID: 34029848.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    11. Favresse J, Bayart JL, Mullier F, Dogné JM, Closset M, Douxfils J. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021 Sep; 27(9):1351.e5-1351.e7. PMID: 33975007.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    12. Favresse J, Eucher C, Elsen M, Gillot C, Van Eeckhoudt S, Dogné JM, Douxfils J. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms. 2021 Mar 08; 9(3). PMID: 33800489.
      Citations: 18     
    13. Haguet H, Douxfils J, Eucher C, Elsen M, Cadrobbi J, Tré-Hardy M, Dogné JM, Favresse J. Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients. J Med Virol. 2021 May; 93(5):3277-3281. PMID: 33599299.
      Citations: 2     Fields:    Translation:Humans
    14. Lardinois B, Favresse J, Chatelain B, Lippi G, Mullier F. Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications. J Clin Med. 2021 Feb 04; 10(4). PMID: 33557431.
      Citations: 3     
    15. Favresse J, Gillot C, Oliveira M, Cadrobbi J, Elsen M, Eucher C, Laffineur K, Rosseels C, Van Eeckhoudt S, Nicolas JB, Morimont L, Dogné JM, Douxfils J. Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection. J Clin Med. 2021 Jan 13; 10(2). PMID: 33450853.
      Citations: 16     
    16. Favresse J, Brauner J, Bodart N, Vigneron A, Roisin S, Melchionda S, Douxfils J, Ocmant A. An original multiplex method to assess five different SARS-CoV-2 antibodies. Clin Chem Lab Med. 2021 04 27; 59(5):971-978. PMID: 33554567.
      Citations: 5     Fields:    Translation:Humans
    17. Favresse J, Elsen M, Eucher C, Laffineur K, Van Eeckhoudt S, Nicolas JB, Gillot C, Dogné JM, Douxfils J. Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients. Clin Chem Lab Med. 2021 04 27; 59(5):e179-e183. PMID: 33554588.
      Citations: 5     Fields:    Translation:Humans
    18. Favresse J, Cadrobbi J, Eucher C, Elsen M, Laffineur K, Dogné JM, Douxfils J. Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins. J Med Virol. 2021 04; 93(4):2262-2269. PMID: 33200836.
      Citations: 11     Fields:    Translation:Humans
    19. Gillot C, Douxfils J, Cadrobbi J, Laffineur K, Dogné JM, Elsen M, Eucher C, Melchionda S, Modaffarri É, Tré-Hardy M, Favresse J. An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens. J Clin Med. 2020 Nov 21; 9(11). PMID: 33233405.
      Citations: 8     
    20. Favresse J, Eucher C, Elsen M, Laffineur K, Dogné JM, Douxfils J. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study. Clin Chem Lab Med. 2020 09 25; 58(10):e193-e196. PMID: 32639942.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    21. Mairesse A, Favresse J, Eucher C, Elsen M, Tré-Hardy M, Haventith C, Gruson D, Dogné JM, Douxfils J, Göbbels P. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Clin Biochem. 2020 Dec; 86:23-27. PMID: 32858061.
      Citations: 11     Fields:    Translation:Humans
    22. Favresse J, Eucher C, Elsen M, Tré-Hardy M, Dogné JM, Douxfils J. Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies. Clin Chem. 2020 08 01; 66(8):1104-1106. PMID: 32484887.
      Citations: 32     Fields:    Translation:HumansCellsPHPublic Health
    23. Tré-Hardy M, Wilmet A, Beukinga I, Favresse J, Dogné JM, Douxfils J, Blairon L. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 02; 93(2):803-811. PMID: 32667733.
      Citations: 23     Fields:    Translation:Humans
    24. Favresse J, Eucher C, Elsen M, Graux C, Goebels P, Laffineur K, Nicolas JB, Dogné JM, Douxfils J. Unexpected kinetics of anti-SARS-CoV-2 total antibodies in two patients with chronic lymphocytic leukemia. Br J Haematol. 2020 08; 190(4):e187-e189. PMID: 32557555.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    Favresse's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (103)
    Explore
    _
    Co-Authors (62)
    Explore
    _
    Similar People (60)
    Explore
    _